Simple blood test could catch hidden heart disease in seniors
NCT ID NCT07238426
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing a way to find cardiac amyloidosis—a rare but serious heart condition—earlier in people aged 65 and older. Researchers in Turkey will screen 800 patients at family medicine clinics using simple blood tests and medical history. The goal is to see if this approach can identify high-risk patients who need further testing.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this screening approach could help doctors spot cardiac amyloidosis earlier in primary care, potentially improving patient outcomes.
- What could go wrong
- This is an early observational study, not a treatment trial. It may not prove that screening improves long-term health, and results may not apply outside this region.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIAC AMYLOIDOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ordu University Faculty of Medicine, Department of Cardiology
Ordu, Ordu, 52200, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Liver clues: a new way to stage heart amyloidosis?
- A carpal tunnel clue to a silent heart threat?
- Heart scans may unlock hidden risks in minority communities
- Pacemaker signals may unmask a rare heart condition
- Can an AI spot hidden heart disease that doctors miss?
- AI eye on the heart: could a computer catch a rare, Often-Missed disease?